Biochemistry Analyzers

Diazyme Laboratories, Inc. is a San Diego-based manufacturer of diagnostic reagents and automated clinical chemistry analyzers. The company specializes in enzyme immunoassay and immunoturbidimetric technologies for automated laboratory analyzers. Product portfolio includes assays for cardiovascular markers (Lp-PLA2 via PLAC® Test, FDA-cleared), cancer markers (kappa and lambda free light chains), sepsis markers (procalcitonin), renal function (cystatin C, creatinine), liver function (total bile acids), diabetic markers (glycated serum protein), gastrointestinal health (calprotectin, lactoferrin), neurodegenerative biomarkers (phosphorylated tau variants, amyloid-beta, neurofilament light chain—mostly in development), and specialty assays (pancreatic elastase, serum amyloid A, vitamin D). The company manufactures the DZ-Lite c270 clinical chemistry analyzer, a fully automated system capable of 270 tests/hour supporting 1–4 reagent assays. Diazyme holds FDA 510(k) clearances for multiple assays and CLIA certification for US distribution. The company serves clinical laboratories, hospitals, and diagnostics networks with liquid-stable, ready-to-use reagent systems compatible with major automated analyzers. Manufacturing and distribution capabilities support both domestic (US) and international markets.

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.

CMB Lab (Consolidated Medical Bio-Analysis, Inc.) is a full-service CLIA and CAP accredited clinical laboratory established in 1979, providing comprehensive diagnostic services to physicians, hospitals, and pharmaceutical companies. The laboratory offers routine blood analyses, HIV testing, anatomic pathology, and advanced genomic testing. CMB specializes in clinical assays and custom assay development for the pharmaceutical and biotechnology sectors, including biomarker testing and validation across Phase I–IV clinical trials. The company operates multiple patient service centers with courier service and maintains a provider web portal for results management. CMB combines clinical laboratory services with dedicated clinical trials and research capabilities, focusing on early disease detection, diagnosis optimization, and therapeutic monitoring.

Bialex Lab is a clinical laboratory reagent manufacturer based in Wichita Falls, Texas, specializing in the development and production of biochemistry assay reagents for clinical diagnostics. The company designs products under IFCC standards and manufactures under FDA section 21 CFR 820 compliance. Bialex serves small and medium enterprises globally with competitively priced, high-quality diagnostic reagents including albumin assays, enzyme kinetics, transaminase tests, and lateral flow assay platforms. The company offers OEM services with custom branding options and no minimum order requirements, positioning itself to fill market gaps not served by larger manufacturers. Products are manufactured in-house with rigorous quality control and double-check processes.

Thermo Fisher Scientific is a global leader in life sciences and laboratory equipment, consumables, and digital solutions. The company manufactures and distributes a comprehensive portfolio of products for research, diagnostics, and bioprocessing applications across academic, pharmaceutical, biotechnology, and clinical laboratory markets. Product lines include transmission electron microscopes (Glacios 3 Cryo-TEM for structural biology), cell culture media and supplements (Gibco brand), molecular biology reagents (TaqMan and SuperScript PCR systems), transfection reagents (Lipofectamine), assay kits, fetal bovine serum, laboratory consumables (tubes, plates, magnetic beads), and analytical instruments. The company serves drug discovery, genomics, proteomics, cell culture, viral production, and materials analysis workflows. Thermo Fisher operates a robust e-commerce platform with online ordering of thousands of SKUs, technical support resources, interactive media selection tools, and educational content. The organization maintains ISO certifications and FDA compliance for its clinical and diagnostic products, with manufacturing facilities and distribution networks across North America and globally.

Onyvia Biolabs (formerly Prove Clinical Laboratories) is a state-of-the-art central laboratory in Sydney's CBD specialising in comprehensive clinical trial services for pharmaceutical companies, biotechs, and CROs. ISO/IEC 17025 accredited by NATA, the laboratory supports Phase I–III trials across multiple therapeutic areas with 6–8 week study startup timelines. Core capabilities include bioanalytical testing via LC-MS/MS and HPLC platforms for pharmacokinetic (PK) analysis, automated ELISA for biomarker testing, safety testing (biochemistry, haematology, coagulation, serology), histopathology with immunohistochemistry and digital imaging, flow cytometry, and PBMC isolation and storage. Additional services encompass kit assembly, sample storage across ambient and ultra-low temperature conditions (-80°C, liquid nitrogen), project management, LIMS database development, international sample logistics, site training, and vendor management. The laboratory is equipped with high-throughput, fully automated analysers and employs a team of PhD-level scientists and clinical pathologists.

Nova Biomedical is a privately held, globally-leading in vitro diagnostic (IVD) company founded in 1976 and headquartered in Waltham, Massachusetts. The largest privately owned diagnostic company in the United States, Nova Biomedical employs over 1,500 people across manufacturing facilities in Massachusetts and Taipei, Taiwan, serving 110+ countries through its global distributor network. The company specializes in advanced blood testing and analytical instrumentation, with a comprehensive portfolio including critical care blood gas analyzers (StatProfile® Prime series), point-of-care glucose meters (StatStrip®, NovaMax®), cell culture analyzers (BioProfile® Flex), clinical and bioprocessing osmometers, liquid volume verification systems, and automated CSF cell counters. Nova Biomedical serves hospitals, emergency departments, blood banks, biotech/pharmaceutical manufacturers, clinical research laboratories, and veterinary diagnostics markets. The company operates through multiple trusted brand portfolios including Advanced Instruments, BioProfile, StatProfile, StatStrip, Artel, Solentim, and GloCyte, delivering solutions for bioprocessing, clinical diagnostics, and veterinary applications with emphasis on improving patient outcomes and operational efficiency.

NuWav Labs is a CLIA-certified, COLA-accredited clinical laboratory offering comprehensive diagnostic solutions including core laboratory testing (chemistry, hematology, immunology), molecular diagnostics (COVID-19, Flu A/B, RSV), and high-quality reagents and kits for healthcare providers and diagnostic laboratories. The company specializes in fast turnaround times with 99% accuracy across 500+ test types, operating under HIPAA compliance and federal regulatory standards. NuWav serves as a scalable diagnostic partner for hospitals, clinics, and research institutions requiring reliable laboratory testing and reagent supply.

ARUP Laboratories is a national, academic, nonprofit reference laboratory established in 1984 as part of the University of Utah's Department of Pathology. Operating 65 highly automated laboratory facilities with 4,300 employees, ARUP serves healthcare providers nationwide with over 3,000 diagnostic tests. The laboratory maintains a two-story freezer capable of storing 2.3 million specimens and provides industry-leading turnaround times. ARUP's test menu encompasses genetics, molecular oncology, pediatrics, neurology, hematopathology, and infectious disease testing. Beyond core laboratory services, ARUP offers comprehensive consulting through its Healthcare Advisory Services division, addressing laboratory stewardship, operations optimization, outreach planning, and data analytics. The company maintains a robust research and innovation program through its Institute for Research and Innovation in Diagnostic and Precision Medicine, supporting clinical trials, pharmaceutical companion diagnostics, and academic research initiatives. ARUP provides ARUP Consult®, a clinical decision support resource featuring testing algorithms and expert insights, alongside continuing education for laboratory professionals. CAP-, CLIA-, and ISO 15189-accredited, ARUP serves academic medical centers, children's hospitals, government facilities, and healthcare systems across the U.S.

Lab Warehouse, Inc. is a clinical laboratory supplier and distributor headquartered in Puerto Rico, established in 1993. The company specializes in hematology, chemistry, urinalysis, and coagulation instruments; rapid diagnostic tests for infectious diseases, pregnancy, and drug screening; laboratory reagents and consumables; and specimen handling equipment including microscopes, centrifuges, and mixers. Lab Warehouse also develops and markets BestLab.net, a comprehensive laboratory information and management system (LIMS) designed for full clinical laboratory automation with compliance to CLIA, HIPAA, and local regulations. The system provides patient data management, quality control programs, electronic billing, workflow analysis, and decision-support analytics for laboratory administrators. The company serves clinical laboratories, physician offices, and veterinary laboratories across Puerto Rico, with expansion into the U.S., Central America, South America, and the Caribbean.

Tecan Group AG is a global life sciences and diagnostics company specializing in laboratory automation, microplate readers, microplate washers, liquid handling systems, and molecular diagnostics solutions. The company serves research institutions, clinical laboratories, and diagnostic centers with a comprehensive portfolio of hardware platforms, reagents, software, and custom automation solutions. Key product lines include the Fluent® and Veya® laboratory automation workstations, Freedom EVO® platform, microplate readers (Spark®, Infinite® series, Sunrise™), and microplate washers (HydroFlex™, HydroSpeed™). The diagnostics division provides mass spectrometry sample preparation systems, positive pressure workstations (Resolvex), and pre/post-analytical automation solutions. Tecan also manufactures next-generation sequencing (NGS) library prep reagents and consumables under brands including Celero, Revelo, and Ultralow DNA-Seq kits. The company's software offerings (FluentControl™, Freedom EVOware®, Magellan™, i-control™, Introspect™) support workflow automation and data management across genomics, proteomics, immunoassay, and clinical diagnostics applications. Manufacturing and OEM partnering services through the Partnering division include liquid handling components, robotic technologies (Cavro systems), and contract manufacturing capabilities. Tecan maintains ISO 13485 quality certification and operates globally with headquarters in Switzerland and significant operations in the US, Europe, and Asia-Pacific. Products are marketed to pharmaceutical research, biotech, clinical laboratories, and diagnostic service providers.

Helena Laboratories is a leading American manufacturer of clinical laboratory instruments and reagents with over 60 years of experience. The company specializes in gel and capillary electrophoresis systems for protein, immunofixation, hemoglobin, and cholesterol testing. Their product portfolio includes the SPIFE Nexus and V8 Nexus CE systems for automated gel and capillary electrophoresis with integrated reporting capabilities, the Touch Series (SPIFE Touch, ESH Touch, QS Touch Plus) for integrated gel electrophoresis with advanced data management and LIS interfaces, and point-of-care hemostasis instruments including Plateletworks for functional platelet analysis and Actalyke ACT analyzers for hemostatic monitoring. Helena also manufactures fecal occult blood (FOBT) test kits, hemostasis reagents, immunology and protein diagnostic systems, and disposable laboratory plasticware. The company maintains corporate headquarters and manufacturing facilities in Beaumont, Texas, comprising over 250,000 square feet of research, manufacturing, inventory, engineering, and administrative space. Helena holds over 40 registered patents and has been awarded the U.S. Secretary of Commerce "E" Award for export excellence. The company serves major medical centers, reference laboratories, hospitals, and private practices worldwide through three international subsidiaries and over 65 international distributors, supported by 24-hour technical hotline service and approximately 75 field specialists throughout the United States.

SEKISUI Diagnostics is a global leader in diagnostic reagents, biochemistry products, and point-of-care testing solutions with over 40 years of industry experience. The company manufactures and supplies clinical chemistry reagents, performing over 1.8 billion tests annually worldwide. Core product lines include Clinical Chemistry reagents for laboratory analyzers, Point-of-Care Testing (POCT) solutions in multiple formats to enable rapid diagnosis in office and clinic settings, and specialty biochemical enzymes for diagnostic reagent and biosensor manufacturers. SEKISUI also provides Blood Collection Tube Raw Materials and pre-analytic systems for plasma collection tubes, serving blood collection manufacturers globally. The Metrix® COVID/Flu Test represents their molecular diagnostics portfolio, offering point-of-care detection and differentiation of SARS-CoV-2, Flu A, and Flu B with small footprint and streamlined workflow. Beyond products, SEKISUI offers Biopharma Services supporting biotherapeutic and pharmaceutical manufacturing, technical transfer, and process scale-up. The company serves core laboratories, healthcare providers, in vitro diagnostics manufacturers, and distributors. SEKISUI combines analytical accuracy with operational efficiency, positioning products for cost containment and outcome improvement across clinical settings. The organization emphasizes patient-centric diagnostic solutions and maintains comprehensive technical and educational support for laboratory and clinical professionals.

QIAGEN is a multinational life sciences company specializing in sample preparation, nucleic acid purification, and molecular diagnostic technologies. The company offers comprehensive solutions including consumable kits for DNA/RNA extraction, automation systems for sample processing, and advanced diagnostic platforms utilizing PCR, digital PCR (dPCR), and next-generation sequencing (NGS). QIAGEN serves diverse markets including clinical laboratories, pharmaceutical and biotech companies, academic research institutions, and organizations in forensics, food safety, and pathogen surveillance. The company provides integrated solutions spanning discovery and translational research, diagnostics and clinical research, human ID and forensics applications, and informatics and data analysis. With over 500,000 customers globally, QIAGEN delivers end-to-end workflows under its "Sample to Insight" philosophy, combining instruments, consumables, and software platforms for molecular testing and biomarker discovery.

Carolina Liquid Chemistries Corp. manufactures and distributes clinical laboratory analyzers and reagents for physician offices, hospitals, and reference laboratories of all sizes. The company's core product portfolio includes the CLC Family of fully automated benchtop and high-volume chemistry analyzers (DZ-Lite c270, CLC800, CLC1600, CLC6410), offering throughputs from 270 to 1,600 tests/hour with integrated ion-selective electrode (ISE) capabilities. CLC markets Tosoh immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and the G8 HPLC analyzer for HbA1c testing, as well as Mindray hematology analyzers (BC-3600, BC-5390). The company supplies a comprehensive reagent line covering 40 general chemistries, 27 urine drug screening assays, 15 immunochemistry tests, and 24 special chemistries including Lp-PLA2, Vitamin D, Procalcitonin, and Human Kappa/Lambda Free Light Chains. CLC offers refurbished Olympus AU and BioLIS 24i/CLC480 chemistry analyzers as cost-effective solutions. The company serves small, rural, and critical access hospitals, providing support for CLIA-regulated testing and maintaining compliance with Clinical Laboratory Improvement Amendments. CLC holds CLIA moderate-complexity categorization for its ethyl alcohol assay and maintains focus on reducing cost, space, and turnaround times for clinical laboratories. The company targets federal buyers including Veterans Affairs (VA) and Department of Defense (DoD) customers. CLC reports over 95% customer satisfaction year-over-year and provides comprehensive service and support infrastructure.

ALPCO (American Laboratory Products Company, Ltd.) is a global in vitro diagnostics (IVD) and research-use-only (RUO) company headquartered in Salem, New Hampshire. Founded in 1991 as an immunoassay importer and distributor, ALPCO has evolved into a leading producer of immunodiagnostic reagents and molecular diagnostics solutions. Following its April 2022 merger with GeneProof, the company enhanced its capabilities in PCR technologies for infectious disease and genetic mutation detection. ALPCO specializes in high-sensitivity immunodiagnostic assays, real-time PCR kits, and multiplex allergy assays with applications across gastroenterology, autoimmune conditions, metabolic disorders, and infectious diseases. The company offers automated sample-to-answer platforms and chemiluminescence-based immunoassays (ELISA, immunoturbidimetric), emphasizing workflow efficiency and supporting clinical laboratories and research facilities globally.

Quest Diagnostics is a large-scale clinical laboratory services provider operating 2,000+ patient service centers across the United States. The company performs over 200 million laboratory tests annually across all patient demographics. Quest offers a comprehensive portfolio of 3,500+ laboratory tests including cardiology markers (Lp(a), ApoB, LDL-C), hematology, biochemistry, genetic testing, prenatal diagnostics (noninvasive prenatal testing, maternal serum screening), and oncology screening. The company serves patients, healthcare professionals, health plans, hospitals, health systems, employers, and life sciences/biopharma organizations. Quest operates significant laboratory automation infrastructure with ongoing modernization efforts and provides IT solutions including Quanum Lab Services Manager for healthcare professionals and healthcare systems. The company recently launched Quest AI Companion, a patient-facing digital tool within MyQuest that provides simplified explanations of lab results. Quest Diagnostics operates a B2B laboratory network model serving as a reference laboratory for hospitals and health systems, providing billing and coding support, and offering population health and workforce health solutions. The organization adheres to clinical laboratory standards and regulatory requirements for laboratory-developed tests.

Shimadzu Medical Systems is a division of Shimadzu Corporation, a Japanese precision instruments and analytical equipment manufacturer founded in 1875. The medical systems segment specializes in diagnostic imaging equipment, particularly advanced X-ray and fluoroscopic systems. Shimadzu manufactures mobile C-arm systems, floor-mounted radiography units with auto-tracking capabilities, mobile X-ray systems, angiography equipment, and fluorescence imaging solutions. The company is recognized for pioneering innovations in medical imaging, including Japan's first medical X-ray device, the world's first remote-controlled X-ray TV system, and fully digital mobile X-ray platforms. These diagnostic imaging systems are designed to support early disease detection and treatment across clinical and hospital settings. Shimadzu also supplies analytical instruments for life science laboratories, including chromatography systems, mass spectrometry equipment, and sample handling solutions, serving pharmaceutical research, clinical diagnostics, and healthcare facilities globally.

Guangzhou Wondfo Biotech Co., Ltd. is a leading in vitro diagnostics (IVD) manufacturer headquartered in Guangzhou, China, founded in 1992. The company employs over 3,000 staff and operates 20+ subsidiaries across 150+ countries. Wondfo specializes in point-of-care testing (POCT) and clinical laboratory diagnostics across eight major technology platforms: Colloidal Gold (rapid diagnostic tests for infectious disease, fertility, drugs-of-abuse); Immunofluorescence (50+ assay reagents and 7 high-performance analyzers for cardiovascular, inflammatory, renal, endocrine, and oncology biomarkers); Chemiluminescence (single-dose immunoassay analyzers with maintenance-free design); Coagulation (optical and semi-automatic blood coagulation analyzers for PT, APTT, TT, FIB, ACT); Blood Gas (portable BGA-102 analyzer delivering results in 30 seconds); Molecular Diagnostics (RT-PCR reagents and platforms for infectious disease including COVID-19); Pathology (PA-3600 automated immunohistochemical staining system); and HPLC Hemoglobin (Truth-H80E analyzer for HbA1c measurement within 60-90 seconds for diabetes diagnosis and monitoring). Products are distributed through clinical laboratories, hospitals, point-of-care settings, emergency departments, and ICUs globally. The Finecare Meter series holds the largest installed base in Chinese medical institutions. Wondfo holds WHO prequalification for select infectious disease products and maintains CE and regulatory compliance across major markets. The company supports healthcare systems with integrated POCT lab solutions and participates actively in international clinical laboratory and diagnostics conferences.

SEBIA is a global in vitro diagnostics company specializing in capillary electrophoresis and protein analysis systems for clinical laboratories. The company manufactures and distributes a comprehensive portfolio of automated instruments, reagent assays, and software solutions for the diagnosis and monitoring of chronic and metabolic diseases, including multiple myeloma, hemoglobinopathies, autoimmune disorders, genetic diseases, and infectious diseases. SEBIA's product range includes standalone and integrated workcell configurations of electrophoresis instruments (such as the Capillaris 3 TERA system) paired with corresponding serum, urine, and specialized protein electrophoresis tests. The company operates in over 120 countries with approximately 20,000 installed instruments worldwide and employs over 1,300 staff. SEBIA offers complementary services including data analysis and interpretation software, Sebia Lean Service (laboratory management and optimization), Sebia Academy (scientific training and education), and Sebia Service (technical and scientific customer support). The company positions itself as providing solutions that translate patient biomarkers into clinically actionable diagnostic information, supporting laboratory efficiency and patient outcomes in clinical chemistry and immunology.

Infrared Laboratory Systems (ILS) manufactures Synermed® brand clinical chemistry reagents designed for automated laboratory analyzers. The company specializes in eliminating common interferences in routine chemistries—hemolysis, icterus, and turbidity—through classical reactions adapted for near-infrared spectrum analysis, where interferents are transparent. ILS reagents are supplied in liquid form, eliminating prep time and enabling on-board stability with simplified reagent management and reduced waste. The technology has undergone five-year worldwide validation across routine tests on commonly-used analyzers. Product portfolio includes chemistry reagents for kinetic creatinine, latent turbidity detection, and infrared-accuracy assays. ILS markets to clinical laboratories seeking to reduce specimen rejection rates, repeat testing, and operational costs while improving analytical accuracy and productivity. The company holds FDA cGMP compliance, ISO 13485 certification, and accreditation as a Notified Body under the Medical Devices Directive.

Alfa Wassermann Diagnostic Technologies (AWDT) manufactures and supplies clinical chemistry analyzers for physician offices, hospitals, veterinary clinics, and the biopharmaceutical industry. The company is part of the larger Alfa Wassermann group, which operates through two primary divisions: AWDT (diagnostic technologies) and AWST (Alfa Wassermann Separation Technologies, focused on ultracentrifuges for vaccine and gene therapy manufacturing). AWDT specializes in reliable, accurate in vitro diagnostic testing solutions with a focus on clinical chemistry analysis. The company serves multiple market segments including human healthcare, veterinary diagnostics, and biopharmaceutical research and manufacturing. Based in West Caldwell, New Jersey, Alfa Wassermann maintains a long-established presence in the diagnostics and separation technology sectors.

Integrated Diagnostics Group (IDG), a division of Sanzay Corporation, is a Miami Gardens-based laboratory diagnostics manufacturer and consolidated distributor serving Latin American and North American markets. IDG designs, manufactures, and distributes clinical laboratory reagents, controls, calibrators, and diagnostic test kits across multiple therapeutic and analytical domains. Product lines include chemistry and immunoassay reagents, calibrators and controls, CLIA/ELISA assays, point-of-care diagnostics, hematology and coagulation reagents, rapid diagnostic tests, serology assays, and urine diagnostic strips. IDG operates as an OEM manufacturer and contract manufacturer, offering bulk supply, private label manufacturing, and consolidated distribution services. The company provides quality assurance services (IDGQAS), laboratory consulting, and integrated sourcing solutions. IDG serves clinical laboratories, hospital laboratory departments, point-of-care testing sites, and diagnostic distributors across Latin America. The company emphasizes efficiency, reliability, and accuracy in product design and manufacturing. Services include sub-manufacturing programs, custom formulation, and consolidated procurement management.

Boule Diagnostics AB is a global provider of diagnostic solutions specializing in hematology analyzers and clinical chemistry systems for decentralized human and veterinary laboratory markets. The company manufactures high-quality hematology and clinical chemistry analyzers alongside associated reagents, controls, and calibrators designed to enhance access to timely and accurate blood test results globally. Through its CDS subsidiary, Boule develops and manufactures custom reagents, controls, and calibrators tailored to partner specifications, serving OEM customers worldwide. The company operates across multiple countries with a distributed network of partners, laboratory systems, and test capacity exceeding millions of tests annually, with significant presence in rural and underserved healthcare areas. Boule's product portfolio is engineered for the decentralized laboratory segment, including point-of-care and smaller clinical laboratory settings in both human and veterinary healthcare sectors.

Verichem Laboratories, Inc. manufactures and distributes clinical chemistry reference kits and calibration materials for diagnostic laboratory analyzers. The company specializes in liquid standards and calibrators designed for wet chemistry methods across major diagnostic platforms including Abbott (ARCHITECT, ALINITY), Beckman Coulter (AU, DxC, UNiCEL), Roche (COBAS, INTEGRA), Siemens (DIMENSION, ATELLICA, ADVIA), Horiba Medical (PENTRA), and other systems. Verichem's product portfolio includes Matrix Plus Chemistry Reference Kits (bovine protein-based liquid standards with optical clarity suitable for visible, UV, kinetic, and endpoint methods), Serum ISE Standard Kits (protein-based gravimetric standards for indirect ISE and flame photometry), and specialized bilirubinometry standards. All non-enzyme standards are FDA Class II Calibrators. The company emphasizes universal product compatibility and cost-effective manufacturing through larger production lots rather than custom analyzer-specific formulations. Verichem provides CLIA-compliant calibration verification reporting and free web-based data reduction software with preloaded definitive targets for all major analyzers and enzyme tests. Technical support is available via phone and email, with lot-specific enzyme targets for Abbott, Beckman, and Roche systems. Standards are traceable to NIST, USP, or recognized reference methods and are formulated without glycol or azide for stability and compatibility. The company serves clinical laboratories, diagnostic manufacturers, and hospital laboratory departments requiring validated calibration and quality control materials.

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Werfen is a global in vitro diagnostics company operating directly in over 30 countries and through distributors in more than 100 territories. The company develops, manufactures, and commercializes diagnostic systems, reagents, software, and services across hemostasis, acute care diagnostics, transfusion, autoimmunity, transplant, immunoassay, and clinical chemistry. Werfen's hemostasis portfolio includes in vitro diagnostic systems and reagents for diagnosing and guiding treatment of thrombotic and bleeding disorders. The acute care diagnostics line provides integrated whole-blood testing solutions for cardiovascular operating rooms, catheterization laboratories, intensive care units, and emergency departments. The transfusion division offers manual and automated solutions with serology reagents, fully automated instrumentation, data management software, and molecular products for donor-recipient compatibility. The autoimmunity segment delivers reagents and lab automation for diagnosing and monitoring autoimmune diseases. Transplant products feature molecular and antibody-based HLA assays and software for pretransplant compatibility determination and post-transplant monitoring. Clinical chemistry solutions serve chemistry and pharma-toxicology laboratories. Werfen also recently completed the acquisition of Omixon, a Budapest-based company specializing in next-generation sequencing technologies for transplant diagnostics. The company maintains a technology center in Bedford, Massachusetts, expanded in December 2024. Werfen's solutions are designed to improve patient care quality, reduce laboratory costs, ensure regulatory compliance, and enhance operational efficiency across clinical laboratory and acute care hospital settings.

QuidelOrtho Corporation is a global in vitro diagnostics company providing diagnostic solutions across clinical laboratory, transfusion medicine, molecular testing, and point-of-care applications. The company offers over 550 assays across multiple testing modalities including real-time PCR, rapid lateral-flow immunoassays, automated immunohematology systems, and benchtop analyzers. Key product platforms include LYRA™ real-time PCR assays (open platform molecular testing), QUICKVUE™ rapid lateral-flow tests for infectious diseases and point-of-care diagnostics, TRIAGE™ System for point-of-care immunoassays, VITROS™ benchtop clinical chemistry systems, SOFIA™ 2 Analyzer for rapid diagnostics, ORTHO VISION™ Swift automated blood bank analyzers, ORTHO™ Workstation semi-automated immunohematology analyzer, and ORTHO OPTIX™ Reader for transfusion lab testing. The company serves clinical laboratories, hospitals, point-of-care settings, and home-testing markets in 140+ countries. QuidelOrtho recently completed acquisition of Lex Diagnostics, expanding its diagnostic portfolio. The company manufactures diagnostic instruments, reagents, and assays for infectious disease detection (virology, molecular, immunoassay), blood banking, clinical chemistry, and specialty testing. Products are regulated as in vitro diagnostic devices under FDA and international standards.

Agilent Technologies is a global leader in laboratory instrumentation, software, supplies, and services serving over 285,000 laboratories across 110 countries. The company manufactures and distributes analytical instruments including liquid chromatography (LC/HPLC) systems, gas chromatography/mass spectrometry (GC/MS), atomic spectroscopy, and cell analysis platforms. Product lines include the 1290 Infinity III LC System with advanced detectors, BioTek Cytation 9 cell imaging multimode reader, and specialized HPLC columns for bio, small-molecule, and GPC/SEC applications. Agilent offers digital pathology solutions, PFAS testing kits, organic chemical standards, and CDMO (contract development and manufacturing organization) services. The company provides comprehensive CrossLab services including instrument maintenance, repair, digital connectivity solutions (CrossLab Connect), software upgrades, and technical training through webinars and educational programs. Agilent supplies consumables, columns, and standards for environmental and food testing, pharmaceutical analysis, and genomics applications. The company serves biopharma, pharmaceutical, environmental, energy, chemicals, semiconductor, and pathology sectors. Agilent emphasizes sustainability, circular economy principles, and supports STEM education globally through the Agilent Foundation.

TECO Diagnostics is a US-based manufacturer of in vitro diagnostic (IVD) test kits and instrumentation headquartered in Anaheim, California, with 30+ years of experience serving over 100 countries. The company operates as an OEM and private-label partner, developing and manufacturing FDA-registered, CE-marked diagnostic products for global distribution. Product lines include urinalysis test strips, rapid diagnostic tests (including alcohol test strips), clinical chemistry reagents, women's health diagnostics, serology testing, animal health products, and laboratory instrumentation. The facility is cGMP-compliant, ISO 13485:2016 certified, and SA 8000 certified. TECO partners with major retailers including Walmart, Amazon, CVS, and Target. The company offers two business models: custom-branded OEM manufacturing for partners seeking private-label solutions, and direct distribution of established product lines. Their strategy team provides R&D support, product troubleshooting, and market-entry consultation. All products meet American manufacturing and quality standards with regulatory clearance for US and international markets.

BUHLMANN Diagnostics Corp is a clinical laboratory diagnostic company specializing in immunoassay and biochemical testing solutions. The company manufactures and distributes FDA-cleared in vitro diagnostic (IVD) assays across multiple therapeutic and diagnostic areas including gastroenterology, autoimmunity, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. Core product lines include calprotectin assays (BÜHLMANN fCAL® turbo and ELISA), pancreatic elastase (BÜHLMANN fPELA® turbo), Quantum Blue® point-of-care and laboratory immunoassay systems, Flow CAST® and CAST® ELISA for allergy testing, and neuroimmunology assays for peripheral neuropathy detection (GanglioCombi® MAG and anti-ganglioside antibody tests). The company offers random-access turbidimetric immunoassays, ELISA-based methods, and extraction technologies (CALEX® Cap) for improved analytical stability and laboratory workflow automation. FDA clearance is documented for multiple products including fCAL® turbo, fCAL® ELISA, fPELA® turbo, ACE KINETIC, and CIC-C1q ELISA. BUHLMANN serves clinical laboratories, hospital pathology departments, gastroenterology centers, and specialty diagnostic facilities. The organization maintains quality management systems and actively participates in medical and scientific conferences (e.g., DDW 2026). Support includes technical customer service, FAQs, and product-specific literature.

EUROIMMUN US Inc. is the North American subsidiary of Euroimmun, a leading German manufacturer of medical laboratory diagnostics founded in 1987. Operating in 18 countries with over 3,400 employees globally, the company specializes in innovative test systems, software, and automation solutions for diagnosing autoimmune diseases, infectious diseases, allergies, neurodegeneration, endocrinology, bone metabolism, and genetic analyses. Headquartered in Mountain Lakes, NJ, EUROIMMUN US supplies clinical laboratories with advanced immunodiagnostic reagents, microarray technologies, and chemiluminescence immunoassay (ChLIA) automation platforms. The company produces comprehensive antibody detection test systems and maintains ISO certifications, serving laboratory medicine professionals with high-quality, standardized diagnostic solutions for autoimmunity, infection control, and specialized clinical parameters.

Tosoh Bioscience, a division of Tosoh Corporation (established 1935, Tokyo Stock Exchange listed), is a global provider of clinical diagnostic analyzers and separation & purification chromatography solutions. The Clinical Diagnostics division serves clinical laboratories, hospitals, and healthcare systems with immunoassay testing platforms and assays spanning oncology, diabetes, fertility, and endocrinology applications. The Separation & Purification division supplies liquid chromatography systems and consumables for biopharma, biotech, chemical, and research industries, with specializations in antibody analysis, biomolecule separation, oligonucleotide purification, and polymer characterization. Key product lines include the AIA-2000 high-throughput immunoassay analyzer, AIA-900 with automated sample handling, SkillPak pre-packed chromatography columns, and LenS3 MALS detector systems. The company operates manufacturing and service capabilities across multiple regions (US, Europe, Japan, China, India, Asia-Pacific) and supports bioprocess development, analytical testing, and research applications. Tosoh maintains a global workforce of over 14,000 across 100+ companies and serves principal markets in chemicals, bioscience, automotive, consumer electronics, and environmental sectors.

Roche Diagnostics is a global leader in in vitro diagnostic (IVD) instruments, assays, and laboratory systems for clinical chemistry, molecular diagnostics, pathology, and specialty testing. The company manufactures high-volume automated analyzer platforms including the cobas® c 703 for clinical chemistry (2,000 tests/hour), cobas® 5800 system for consolidated automation and integration, and Digital LightCycler® System for digital PCR applications. Product offerings span core lab chemistry, hematology, immunochemistry, mass spectrometry solutions (including Ionify® steroid assays), tissue diagnostics with ready-to-use oncology assays, and blood-based biomarker testing (e.g., pTau181 for Alzheimer's-related amyloid pathology). The organization serves laboratory professionals, clinicians, researchers, and patients across multiple laboratory settings. Roche maintains FDA clearances and 510(k) approvals for its analytical systems and assays, with CLIA moderate-complexity categorization for specialized tests. The company provides comprehensive support including eLabDoc document library access (800,000+ documents), e-learning platforms, PACE/CEU accredited training, and clinical education resources. Manufacturing and regulatory operations are supported from US facilities including Indianapolis headquarters.

Diamond Diagnostics Inc. is a specialized clinical laboratory instrumentation and consumables supplier based in Holliston, Massachusetts, founded in 1996. The company manufactures, remanufactures, and supplies new and refurbished chemistry analyzers, electrolyte analyzers, immunoassay systems, blood gas analyzers, coagulation analyzers, hematology analyzers, and molecular analyzers. With approximately 80 employees and ~$19M annual revenue, Diamond offers over 500 consumable products including reagents, quality controls, and electrodes. The company's proprietary Down-To-Frame® refurbishment process restores equipment to like-new condition. Most products hold FDA clearance and CE approval. Diamond provides comprehensive field service, depot service, preventive maintenance, remote support, control assay, and refurbishment services to clinical laboratories and hospitals globally. ISO 9001:2015 and ISO 13485:2016 certified, the company also offers OEM and contract manufacturing for third-party organizations.

Awareness Technology, Inc. is an ISO 13485:2016 certified manufacturer of in vitro diagnostic (IVD) instruments, reagents, and assays established in 1982. Based in Palm City, Florida, the company specializes in automated and semi-automated clinical laboratory systems tailored for small- to medium-sized labs. Core product lines include chemistry analyzers, microplate readers, microplate washers, and incubator/shakers. The company manufactures ELISA reagents, biochemistry kits, and specialized chemiluminescence and automated RPR analyzers. Awareness Technology provides full-service OEM production capabilities with custom instrument design, field-proven reliability, ease of use, and cost-effective solutions. The company serves over 200 countries across Asia, Africa, the Middle East, and the South Pacific, supporting routine health screening, autoimmune testing, infectious disease detection, and food science testing applications.

MedicalSystem Biotechnology Co., Ltd. is a global in-vitro diagnostics (IVD) solution provider founded in Ningbo, China, in 2003. The company operates a complete value chain from R&D through commercial services, serving clinical laboratories, hospitals, and diagnostic centers across 100+ countries. With ~2,500 employees globally and 22+ years of IVD experience, MedicalSystem specializes in automated clinical laboratory analyzers for biochemistry, chemiluminescence immunoassay, and blood lipid subfraction analysis. Primary product lines include the MS-380P (compact fully-automated chemistry analyzer), MS-i2280 (chemiluminescence immunoassay system integrating reagents and instruments), and VAP Series (advanced analyzers for cardiovascular risk assessment via lipid subfractionation). The company emphasizes reliable, easy-to-use diagnostic solutions designed for continuous laboratory operations. Products combine instrumentation with reagents to support accurate clinical decision-making across diverse laboratory settings. Manufacturing and service capabilities span R&D, production, quality assurance, and after-sales support. No specific FDA 510(k), CE, or ISO certifications are stated on the fetched content, though the company's international distribution and regulatory compliance are implied by presence in 100+ countries.

Randox Laboratories is a global leader in diagnostic solutions with over 40 years of expertise in clinical laboratory, molecular, and point-of-care diagnostics. The company manufactures a comprehensive portfolio including the RX Series clinical chemistry analyzers, Vivalytic molecular point-of-care systems, and Evidence Series immunoassay analyzers. Randox provides open-channel reagents covering more than 100 disease areas including autoimmune disorders, cancers, and emergency/critical care diagnostics. The company operates as the world's largest external quality assessment (EQA) provider through RIQAS and QCMD platforms, serving over 100,000 users across 145 countries. Core offerings include quality control solutions (Acusera brand), third-party diagnostic assays, molecular infectious disease controls, and QC data management software. Beyond laboratory equipment, Randox operates multiple specialized service divisions: Contract Manufacturing (OEM partnerships), CDx and Biopharma services (biomarker development), Genomics (end-to-end sequencing with in-house bioinformatics), Pathology Services (sample collection and advanced testing), Toxicology (forensic drug detection for 600+ substances), Workplace Drug and Alcohol Testing, Food Diagnostics (antimicrobial and toxin screening), and Randox Health (preventative healthcare and home testing kits). The company serves clinical laboratories, reference labs, pharmaceutical companies, food/beverage industry, workplace testing, and forensic applications globally.

Since 1986, Jant Pharmacal Corporation has been a leading B2B supplier of point-of-care (POC) diagnostic tests and laboratory instrumentation to U.S. and international healthcare settings. The company operates two primary divisions: POC Division and Lab Division. The POC Division offers CLIA-waived rapid tests and analyzers for use in physicians' offices, clinics, urgent care centers, and hospitals under registered trademarks Accutest, Accustrip, and LipidPlus. Product categories include cardiac testing, colorectal cancer screening, drugs of abuse, hypothyroidism, infectious diseases, pregnancy & fertility, and urinalysis. The Lab Division provides integrated solutions for laboratory optimization, featuring clinical chemistry, hematology, immunoassay, toxicology, urinalysis, and molecular diagnostic systems with reagents and consumables. The company holds GPO supplier contracts with Vizient and Champs, representing over 500,000 members. Additionally, Jant offers laboratory consultation services including financial feasibility assessment, turn-key laboratory setup, CLIA compliance consultation, LCMS method development, and laboratory information system integration.

Isla Lab Products, LLC is a Puerto Rico–based medical laboratory distributor and supplier founded in 1977 and expanded to the Caribbean in 2007. Headquartered at Amelia Industrial Park in Guaynabo, PR, the company operates a 30,000-square-foot facility with sales, customer service, technical and professional support, cold chain distribution, conference facilities, and a training center. The company distributes and supplies a comprehensive portfolio of clinical laboratory analyzers, reagents, consumables, and diagnostics across multiple specialties: clinical chemistry, immunochemistry, microbiology, hematology, transfusion medicine and blood banking, point-of-care testing, molecular diagnostics, pathology, toxicology, coagulation studies, COVID-19 testing, and rapid diagnostics. Key product offerings include automated chemistry analyzers (cobas® c 513, cobas® pure), microbiology identification and blood culture systems (VITEK® 2, BACT/ALERT® VIRTUO®, BACT/ALERT® 3D), rapid antigen testing platforms (Quidel Sofia 2), blood collection tubes (Vacuette®), and hematology analyzers (BC-5390). The company serves clinical laboratories, hospitals, diagnostic centers, and healthcare institutions across Puerto Rico and the Caribbean islands. Isla Lab Products maintains technical service capabilities, professional training, and cold chain logistics to support customer operations. The company operates as an authorized distributor for major in vitro diagnostics manufacturers and provides B2B procurement solutions for laboratory testing infrastructure and consumables.

Beckman Coulter Diagnostics is a global leader in clinical diagnostics and biomedical testing, headquartered in Brea, California. A subsidiary of Danaher Corporation since its foundational 1935 establishment, the company develops, manufactures, and distributes innovative laboratory automation systems, analyzers, and informatics solutions for clinical and research laboratories worldwide. The company specializes in clinical chemistry systems, immunoassay instruments, hematology analyzers, urinalysis systems, microbiology solutions, blood banking instruments, and protein chemistry platforms. Beckman Coulter also provides total lab automation systems (DxA 5000 series), advanced informatics middleware (Remisol Advance), and remote diagnostic services. Its comprehensive portfolio supports healthcare professionals and laboratory teams in disease diagnosis, treatment decisions, patient monitoring, and improved health outcomes. With annual revenue of approximately $2.9 billion, the company emphasizes efficiency, automation, clinical confidence, and integrated workflow solutions for hospital laboratories, reference laboratories, and blood banks globally.

Biobase Biodustry (Shandong) Co., Ltd is a high-tech manufacturer founded in 1999, headquartered in Jinan, Shandong, China. The company operates 25 manufacturing facilities and provides comprehensive one-stop solutions for laboratory, medical, and clinical applications. Core product categories include biological safety cabinets, laminar flow cabinets, fume hoods, sterilization equipment (autoclaves, sterilizers), clinical and analytical instruments (auto chemistry analyzers, electrolyte analyzers, blood bank refrigerators), flow cytometers, PCR cabinets, laboratory cryogenic refrigeration units, and hospital furniture (beds, wheelchairs). Biobase serves research institutions, clinical laboratories, diagnostic facilities, and healthcare providers across more than 190 countries. The company maintains in-house R&D (100+ employees), sales (200+ employees), and after-sales support teams (11+ employees). Certifications include ISO 9001, ISO 13485, ISO 14001, CE, FDA, NSF, SGS, and EN standards, reflecting compliance with international quality and medical device regulations. Services include 24-hour online customer support and warranty coverage for defective components.

High Technology, Inc. (HTI) manufactures laboratory analyzers engineered specifically for emerging healthcare systems and resource-constrained environments. The company specializes in clinical diagnostic equipment including hematology, clinical chemistry, electrolyte, urinalysis, and coagulation analyzers. HTI's core value proposition centers on delivering reliable diagnostic performance in real-world conditions—fluctuating power supply, varying ambient temperatures, and challenging infrastructure—without requiring ideal laboratory conditions. Products feature intuitive touchscreen interfaces with multilingual support, role-based access controls, and are designed for operation across diverse skill levels. HTI operates a distributor-partnership model, offering exclusive territorial agreements, factory training and certification programs, protected distribution channels, and regional support teams across Africa, Latin America, Asia, and Eastern Europe. The company also manufactures veterinary diagnostic analyzers using the same robust, real-world-focused engineering principles. Products mentioned include the HTI MicroCC-25 Plus, a 5-part hematology analyzer designed for community outpatient labs, rural clinics, district hospitals, and maternal health programs. HTI emphasizes consistent reagent supply chains, data protection, and sustainable local partnerships rather than treating distributors as replaceable sales channels. The organization positions itself as a healthcare infrastructure builder serving mid-market and emerging-economy clinical settings.

Diatron U.S. Inc, a member of the STRATEC group, is a manufacturer of in vitro diagnostic (IVD) analyzers and reagents for clinical laboratory use. The company specializes in hematology analyzers, clinical chemistry analyzers, and immunoassay systems. Product lines include the Aquila, Aquarius 3, Abacus 5, Abacus 380, and Abacus Junior 30 hematology analyzers for human clinical diagnostics, along with the Abacus Vet5 for veterinary applications. Clinical chemistry offerings include the Pictus 500 (P500), Pictus 700, and P780 fully automated analyzers. Immunoassay capabilities include the GEMINI ELISA system and KleeYa chemiluminescent analyzer. Diatron also manufactures hematology reagents, controls, calibrators, and clinical chemistry reagents to support its analyzer platforms. The company serves clinical laboratories, hospital laboratory departments, and reference laboratories globally. Manufacturing capabilities include reagent development, quality control testing, and technical support services. The company maintains quality management systems and operates a distributor network for market reach and customer support.

Immundiagnostik, Inc. is the North American subsidiary of Immundiagnostik AG, a clinical laboratory diagnostics company specializing in immunoassay-based detection solutions. The company develops and distributes ELISA kits and automated chemiluminescent analyzers for research and clinical laboratory applications across multiple therapeutic areas including cardiovascular and renal disease, bone and mineral metabolism, immunology, and complementary health. Their flagship product is the ECL100 Chemiluminescent Immunoassay Analyzer, a high-throughput automated platform for laboratory testing. The product portfolio includes specialized ELISA kits such as ox-LDL (oxidized low-density lipoprotein), 1,25-(OH)2 Vitamin D, EDN (endothelin), and HERO (Histamine Elimination Ratio) assays. Immundiagnostik serves clinical laboratories, research institutions, and healthcare facilities requiring sensitive and reliable biomarker detection. The company provides comprehensive support services including expert-guided assay validation assistance, custom bulk packaging solutions, technical support, and on-site training. They participate in major medical conferences (e.g., DDW 2026) and maintain a regional sales structure across North America with dedicated sales directors. The company is positioned as a supplier of both detection instrumentation and consumable assay kits for specialized laboratory diagnostics.